Village-integrated eye workers for prevention of corneal ulcers in Nepal (VIEW study): a cluster-randomised controlled trial.


Journal

The Lancet. Global health
ISSN: 2214-109X
Titre abrégé: Lancet Glob Health
Pays: England
ID NLM: 101613665

Informations de publication

Date de publication:
04 2022
Historique:
received: 14 09 2021
revised: 09 12 2021
accepted: 14 12 2021
pubmed: 19 3 2022
medline: 22 4 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

Corneal ulcers are a common cause of blindness in low-income and middle-income countries, usually resulting from traumatic corneal abrasions during agricultural work. Antimicrobial prophylaxis of corneal abrasions can help prevent corneal ulcers, but delays in the initiation of therapy are frequent. We aimed to assess whether a community-based programme for corneal ulcer prevention would reduce the incidence of corneal ulceration. A cluster-randomised trial was performed in village development committees (VDCs) in Nepal. VDCs in the catchment area of Bharatpur Eye Hospital, Nepal with less than 15 000 people were eligible for inclusion. We randomly assigned (1:1) VDCs to either an intervention group or a control group. In the intervention VDCs, existing female community health volunteers (FCHVs) were trained to diagnose corneal abrasions and provide a 3-day course of ophthalmic antimicrobials to their patients. In the control VDCs, FCHVs did not provide this intervention. Participants were not masked given the nature of the intervention. Both groups were followed up for 3 years for photographic evidence of corneal ulceration. The primary outcome was the incidence of corneal ulceration, determined by masked assessment of corneal photographs. The analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT01969786. We assessed 112 VDCs, of which 24 were enrolled. The study was performed between Feb 4, 2014, and Oct 20, 2017. 12 VDCs were randomly assigned to the intervention group and 12 to the control group. 252 539 individuals were included in the study (130 579 in the intervention group and 121 960 in the control group). FCHVs diagnosed and provided antimicrobials for 4777 corneal abrasions. The census identified 289 corneal ulcers among 246 893 person-years in the intervention group (incidence 1·21 cases [95% CI 0·85-1·74] per 1000 person-years) and 262 corneal ulcers among 239 170 person-years in the control group (incidence 1·18 cases [0·82-1·70] per 1000 person-years; incidence rate ratio 1·03 [95% CI 0·63-1·67]; p=0·93). Medication allergy was self-reported in 0·2% of participants. We did not detect a reduction in the incidence of corneal ulceration during the first 3 years of a community-based corneal ulcer prevention programme. Further study might be warranted in more rural areas where basic eye care facilities are not available. National Eye Institute.

Sections du résumé

BACKGROUND
Corneal ulcers are a common cause of blindness in low-income and middle-income countries, usually resulting from traumatic corneal abrasions during agricultural work. Antimicrobial prophylaxis of corneal abrasions can help prevent corneal ulcers, but delays in the initiation of therapy are frequent. We aimed to assess whether a community-based programme for corneal ulcer prevention would reduce the incidence of corneal ulceration.
METHODS
A cluster-randomised trial was performed in village development committees (VDCs) in Nepal. VDCs in the catchment area of Bharatpur Eye Hospital, Nepal with less than 15 000 people were eligible for inclusion. We randomly assigned (1:1) VDCs to either an intervention group or a control group. In the intervention VDCs, existing female community health volunteers (FCHVs) were trained to diagnose corneal abrasions and provide a 3-day course of ophthalmic antimicrobials to their patients. In the control VDCs, FCHVs did not provide this intervention. Participants were not masked given the nature of the intervention. Both groups were followed up for 3 years for photographic evidence of corneal ulceration. The primary outcome was the incidence of corneal ulceration, determined by masked assessment of corneal photographs. The analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT01969786.
FINDINGS
We assessed 112 VDCs, of which 24 were enrolled. The study was performed between Feb 4, 2014, and Oct 20, 2017. 12 VDCs were randomly assigned to the intervention group and 12 to the control group. 252 539 individuals were included in the study (130 579 in the intervention group and 121 960 in the control group). FCHVs diagnosed and provided antimicrobials for 4777 corneal abrasions. The census identified 289 corneal ulcers among 246 893 person-years in the intervention group (incidence 1·21 cases [95% CI 0·85-1·74] per 1000 person-years) and 262 corneal ulcers among 239 170 person-years in the control group (incidence 1·18 cases [0·82-1·70] per 1000 person-years; incidence rate ratio 1·03 [95% CI 0·63-1·67]; p=0·93). Medication allergy was self-reported in 0·2% of participants.
INTERPRETATION
We did not detect a reduction in the incidence of corneal ulceration during the first 3 years of a community-based corneal ulcer prevention programme. Further study might be warranted in more rural areas where basic eye care facilities are not available.
FUNDING
National Eye Institute.

Identifiants

pubmed: 35303460
pii: S2214-109X(21)00596-9
doi: 10.1016/S2214-109X(21)00596-9
pmc: PMC9814976
mid: NIHMS1860582
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01969786']

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e501-e509

Subventions

Organisme : NEI NIH HHS
ID : U10 EY022880
Pays : United States

Investigateurs

Muthiah Srinivasan (M)
Raghunandan Byanju (R)
Kamal Bahadur Khadka (KB)
Dikshya Bista (D)
Mariya Gautam (M)
Puspa Giri (P)
Sajani Kayastha (S)
Tulsi Prasad Parajuli (TP)
Ranjeet Kumar Shah (RK)
Niraj Sharma (N)
Prafulla Sharma (P)
Anju Shrestha (A)
Manisha Shrestha (M)
Pradeep Subedi (P)
Daya Shankar Chaudhary (DS)
Ramesh Ghimire (R)
Manmohan Adhikari (M)
Vivek Hamal (V)
Gopal Bhandari (G)
Gokul Dahal (G)
Bimal Poudyal (B)
Sadhan Bhandari (S)
Jeevan Gurung (J)
Dipak Bhattarai (D)
Rabin Bhattarai (R)
Dipak Chapagain (D)
Ajay Kumar Chaudhary (AK)
Shree Krishna Gautam (SK)
Dhanmaya Gurau (D)
Deepak Kandel (D)
Pradip Chandara Lamichhane (PC)
Rajendra Rijal (R)
Gaurav Giri (G)
Madan Upadhyay (M)
Thomas M Lietman (TM)
Nisha R Acharya (NR)
John A Gonzales (JA)
Jeremy D Keenan (JD)
Stephen D McLeod (SD)
David A Ramirez (DA)
Kathryn J Ray (KJ)
Jennifer Rose-Nussbaumer (J)
John P Whitcher (JP)
Kieran S O'Brien (KS)
Sun Y Cotter (SY)
Jessica Kim (J)
Salena Lee (S)
Robi N Maamari (RN)
Travis C Porco (TC)
Ken Basset (K)
Heidi Chase (H)
Lauren Evans (L)
Suzanne Gilbert (S)
Ram Prasad Kandel (RP)
Deborah Moses (D)
Chundak Tenzing (C)
Shravan Choudhary (S)
Parami Dhakwa (P)
Daniel A Fletcher (DA)
Clay D Reber (CD)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests We declare no competing interests.

Références

Ophthalmic Res. 2005 May-Jun;37(3):123-7
pubmed: 15746569
Am J Ophthalmol. 2022 May;237:259-266
pubmed: 34942106
Cornea. 2010 Dec;29(12):1380-5
pubmed: 20847686
Br J Ophthalmol. 1997 Nov;81(11):965-71
pubmed: 9505820
Br J Ophthalmol. 2001 Apr;85(4):388-92
pubmed: 11264124
Arch Ophthalmol. 2012 Feb;130(2):151-7
pubmed: 21987581
Nepal J Ophthalmol. 2016 Jul;8(16):128-138
pubmed: 28478466
Int J Ophthalmol. 2014 Jun 18;7(3):557-62
pubmed: 24967208
Am J Ophthalmol. 2018 Nov;195:161-170
pubmed: 30098351
Br J Ophthalmol. 2006 Mar;90(3):276-8
pubmed: 16488943
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Int Ophthalmol Clin. 2007 Summer;47(3):17-25
pubmed: 17667273
Am J Trop Med Hyg. 2020 Oct;103(4):1694-1696
pubmed: 32700676
Br J Ophthalmol. 2006 Dec;90(12):1472-5
pubmed: 16916874
Cochrane Database Syst Rev. 2016 Jul 26;7:CD004764
pubmed: 27457359
Cornea. 2002 Aug;21(6):555-9
pubmed: 12131029
Nepal Med Coll J. 2012 Sep;14(3):219-22
pubmed: 24047020
Ophthalmic Epidemiol. 2022 Oct;29(5):491-498
pubmed: 34607500
Bull World Health Organ. 2001;79(3):214-21
pubmed: 11285665
Am J Ophthalmol. 2014 Feb;157(2):327-333.e3
pubmed: 24315294
Br J Ophthalmol. 2006 Aug;90(8):968-70
pubmed: 16707522
BMC Ophthalmol. 2016 Nov 29;16(1):209
pubmed: 27899093
Ophthalmic Epidemiol. 1996 Dec;3(3):159-66
pubmed: 8956320
BMJ Open. 2018 Aug 10;8(8):e021556
pubmed: 30099393
Ophthalmology. 2004 Sep;111(9):1778-81
pubmed: 15350336
Arch Ophthalmol. 2007 Jun;125(6):789-93
pubmed: 17562990
Nepal J Ophthalmol. 2012 Jan-Jun;4(1):119-27
pubmed: 22344009
Am J Ophthalmol. 1991 Jan 15;111(1):92-9
pubmed: 1985498

Auteurs

Kieran S O'Brien (KS)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.

Raghunandan Byanju (R)

Bharatpur Eye Hospital, Bharatpur, Nepal.

Ram P Kandel (RP)

Bharatpur Eye Hospital, Bharatpur, Nepal; Seva Foundation Berkeley, Berkeley, CA, USA; Seva Foundation Kathmandu, Kathmandu, Nepal.

Bimal Poudyal (B)

Bharatpur Eye Hospital, Bharatpur, Nepal.

John A Gonzales (JA)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.

Travis C Porco (TC)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.

John P Whitcher (JP)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA.

Muthiah Srinivasan (M)

Aravind Eye Care System, Madurai, India.

Madan Upadhyay (M)

BP Eye Foundation, Children's Hospital for Eye, Ear, and Rehabilitation Services (CHEERS), Kathmandu, Nepal.

Thomas M Lietman (TM)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA.

Jeremy D Keenan (JD)

Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA; Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA. Electronic address: jeremy.keenan@ucsf.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH